BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1156 related articles for article (PubMed ID: 21835295)

  • 1. Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: dependent or independent risk factors?
    Anderson JL; Vanwoerkom RC; Horne BD; Bair TL; May HT; Lappé DL; Muhlestein JB
    Am Heart J; 2011 Aug; 162(2):331-339.e2. PubMed ID: 21835295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of vitamin D levels with incident depression among a general cardiovascular population.
    May HT; Bair TL; Lappé DL; Anderson JL; Horne BD; Carlquist JF; Muhlestein JB
    Am Heart J; 2010 Jun; 159(6):1037-43. PubMed ID: 20569717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population.
    Anderson JL; May HT; Horne BD; Bair TL; Hall NL; Carlquist JF; Lappé DL; Muhlestein JB;
    Am J Cardiol; 2010 Oct; 106(7):963-8. PubMed ID: 20854958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP).
    Bhuriya R; Li S; Chen SC; McCullough PA; Bakris GL
    Am J Kidney Dis; 2009 Apr; 53(4 Suppl 4):S3-10. PubMed ID: 19285609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parathyroid hormone as a mortality predictor in frail aged inpatients.
    Bjorkman M; Sorva A; Tilvis R
    Gerontology; 2009; 55(6):601-6. PubMed ID: 19752529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Review of the concept of vitamin D "sufficiency and insufficiency"].
    Gómez Alonso C; Naves Díaz M; Rodríguez García M; Fernández Martín JL; Cannata Andía JB
    Nefrologia; 2003; 23 Suppl 2():73-7. PubMed ID: 12778859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum parathyroid hormone and risk of adverse outcomes in patients with stable coronary heart disease.
    Grandi NC; Breitling LP; Hahmann H; Wüsten B; März W; Rothenbacher D; Brenner H
    Heart; 2011 Aug; 97(15):1215-21. PubMed ID: 21586795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated serum PTH is independently associated with poor outcomes in older patients with hip fracture and vitamin D inadequacy.
    Fisher A; Goh S; Srikusalanukul W; Davis M
    Calcif Tissue Int; 2009 Oct; 85(4):301-9. PubMed ID: 19763373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survey of attitudes of physicians toward the current evaluation and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).
    Souqiyyeh MZ; Shaheen FA
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):93-101. PubMed ID: 20061700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D deficiency and associated factors in hemodialysis patients.
    Jean G; Charra B; Chazot C
    J Ren Nutr; 2008 Sep; 18(5):395-9. PubMed ID: 18721733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperparathyroidism and vitamin D deficiency after laparoscopic gastric bypass.
    Clements RH; Yellumahanthi K; Wesley M; Ballem N; Bland KI
    Am Surg; 2008 Jun; 74(6):469-474; discussion 474-5. PubMed ID: 18556987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosing hypovitaminosis D: serum measurements of calcium, phosphate, and alkaline phosphatase are unreliable, even in the presence of secondary hyperparathyroidism.
    Smith GR; Collinson PO; Kiely PD
    J Rheumatol; 2005 Apr; 32(4):684-9. PubMed ID: 15801026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevalence of secondary hyperparathyroidism (SHPT) and causal factors in adult population in Reykjavík area].
    Karlsson SL; Indridason OS; Franzson L; Sigurdsson G
    Laeknabladid; 2005 Feb; 91(2):161-9. PubMed ID: 16155312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and impact of vitamin D insufficiency in southern Chinese adults.
    Wat WZ; Leung JY; Tam S; Kung AW
    Ann Nutr Metab; 2007; 51(1):59-64. PubMed ID: 17356256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hip fracture type: important role of parathyroid hormone (PTH) response to hypovitaminosis D.
    Fisher A; Srikusalanukul W; Davis M; Smith P
    Bone; 2010 Aug; 47(2):400-7. PubMed ID: 20451678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated serum parathyroid hormone is a cardiovascular risk factor in moderate chronic kidney disease.
    Lishmanov A; Dorairajan S; Pak Y; Chaudhary K; Chockalingam A
    Int Urol Nephrol; 2012 Apr; 44(2):541-7. PubMed ID: 21327525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glomerular filtration rate and parathyroid hormone are associated with 1,25-dihydroxyvitamin D in men without chronic kidney disease.
    Karhapää P; Pihlajamäki J; Pörsti I; Kastarinen M; Mustonen J; Niemelä O; Tuomi H; Kuusisto J
    J Intern Med; 2012 Jun; 271(6):573-80. PubMed ID: 21995281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D and parathyroid hormone in outpatients with noncholestatic chronic liver disease.
    Fisher L; Fisher A
    Clin Gastroenterol Hepatol; 2007 Apr; 5(4):513-20. PubMed ID: 17222588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aldosterone and parathyroid hormone interactions as mediators of metabolic and cardiovascular disease.
    Tomaschitz A; Ritz E; Pieske B; Rus-Machan J; Kienreich K; Verheyen N; Gaksch M; Grübler M; Fahrleitner-Pammer A; Mrak P; Toplak H; Kraigher-Krainer E; März W; Pilz S
    Metabolism; 2014 Jan; 63(1):20-31. PubMed ID: 24095631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 58.